Literature DB >> 34112846

Automated home-cage for the evaluation of innate non-reflexive pain behaviors in a mouse model of inflammatory pain.

Peththa Wadu Dasuni Wasana1, Opa Vajragupta2, Pornchai Rojsitthisak3,4, Pasarapa Towiwat5,6.   

Abstract

The failure to develop analgesic drugs is attributed not only to the complex and diverse pathophysiology of pain in humans but also to the poor experimental design and poor preclinical assessment of pain. Although considerable efforts have been devoted to overcoming the relevant problems, many features of the behavioral pain assessment remain to be characterized. For example, a decreased locomotor activity as a common presentation of pain-like behavior has yet to be described. Studies on mice experimentally induced with carrageenan have provided opportunities to explore pain-related behaviors in automated home-cage monitoring. Through this approach, the locomotor activities of mice with carrageenan-induced inflammatory pain can be precisely and objectively captured. Here, we found that the mobile behaviors of mice reduced, and their immobility increased, indicating that carrageenan induction in mice caused a significant decrease in locomotor activity. These non-reflexive pain behaviors were strongly correlated with the reflexive pain behaviors measured via von Frey and plantar tests. Furthermore, the pharmacological intervention using indomethacin improved the locomotor activity of mice with carrageenan-induced pain. Thus, the analysis of the locomotor activity in automated home-cage monitoring is useful for studying the behavioral analgesia and the pharmacological screening of analgesic drugs. The combined evaluation of reflexive and non-reflexive pain behaviors enhances the translational utility of preclinical pain research in rodents.

Entities:  

Year:  2021        PMID: 34112846     DOI: 10.1038/s41598-021-91444-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

1.  Did experimenter bias conceal the efficacy of spinal opioids in previous studies with the spinal nerve ligation model of neuropathic pain?

Authors:  James C Eisenach; Mark D Lindner
Journal:  Anesthesiology       Date:  2004-04       Impact factor: 7.892

Review 2.  Clinical and pre-clinical pain assessment: are we measuring the same thing?

Authors:  C J Vierck; P T Hansson; R P Yezierski
Journal:  Pain       Date:  2008-01-22       Impact factor: 6.961

Review 3.  Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents.

Authors:  Anke Tappe-Theodor; Tamara King; Michael M Morgan
Journal:  Neurosci Biobehav Rev       Date:  2019-03-15       Impact factor: 8.989

4.  Clinical development success rates for investigational drugs.

Authors:  Michael Hay; David W Thomas; John L Craighead; Celia Economides; Jesse Rosenthal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

5.  Neuropathic pain symptoms relative to overall pain rating.

Authors:  Misha-Miroslav Backonja; Brett Stacey
Journal:  J Pain       Date:  2004-11       Impact factor: 5.820

Review 6.  The molecular basis of pain and its clinical implications in rheumatology.

Authors:  Brendan Bingham; Seena K Ajit; David R Blake; Tarek A Samad
Journal:  Nat Clin Pract Rheumatol       Date:  2009-01

Review 7.  A Review of Pain Assessment Methods in Laboratory Rodents.

Authors:  Patricia V Turner; Daniel Sj Pang; Jennifer Ls Lofgren
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

Review 8.  Animal models of pain: progress and challenges.

Authors:  Jeffrey S Mogil
Journal:  Nat Rev Neurosci       Date:  2009-03-04       Impact factor: 34.870

Review 9.  Pain and immunity: implications for host defence.

Authors:  Pankaj Baral; Swalpa Udit; Isaac M Chiu
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

Review 10.  Emotional and Motivational Pain Processing: Current State of Knowledge and Perspectives in Translational Research.

Authors:  Susanne Becker; Edita Navratilova; Frauke Nees; Stefaan Van Damme
Journal:  Pain Res Manag       Date:  2018-07-18       Impact factor: 3.037

View more
  4 in total

1.  Curcumin Diethyl γ-Aminobutyrate, a Prodrug of Curcumin, for Enhanced Treatment of Inflammatory Pain.

Authors:  Peththa Wadu Dasuni Wasana; Piyapan Suwattananuruk; Somphob Thompho; Worathat Thitikornpong; Opa Vajragupta; Pornchai Rojsitthisak; Pasarapa Towiwat
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-05

2.  Combination of curcumin and piperine synergistically improves pain-like behaviors in mouse models of pain with no potential CNS side effects.

Authors:  Pawana Boonrueng; Peththa Wadu Dasuni Wasana; Opa Vajragupta; Pornchai Rojsitthisak; Pasarapa Towiwat
Journal:  Chin Med       Date:  2022-10-23       Impact factor: 4.546

3.  Curcumin and metformin synergistically modulate peripheral and central immune mechanisms of pain.

Authors:  Peththa Wadu Dasuni Wasana; Chawanphat Muangnoi; Opa Vajragupta; Pranee Rojsitthisak; Pornchai Rojsitthisak; Pasarapa Towiwat
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

4.  Atp11b Deletion Affects the Gut Microbiota and Accelerates Brain Aging in Mice.

Authors:  Cuiping Liu; Shibo Zhang; Hongwei Shi; Haicong Zhou; Junyi Zhuang; Yiyang Cao; Natalie Ward; Jiao Wang
Journal:  Brain Sci       Date:  2022-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.